A preservative free generic alternative to DuoNeb® (Ipratropium Bromide Bar Coded; Available in the following package configurations per box. Mylan Specialty: DuoNeb is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one. Prescription Drug Information: Duoneb. Ritedose Pharmaceuticals DUONEB- ipratropium bromide and albuterol sulfate solution. Ritedose.

Author: Doulmaran Faesida
Country: French Guiana
Language: English (Spanish)
Genre: Marketing
Published (Last): 17 January 2010
Pages: 330
PDF File Size: 20.16 Mb
ePub File Size: 10.2 Mb
ISBN: 287-9-87514-227-1
Downloads: 16013
Price: Free* [*Free Regsitration Required]
Uploader: Ferisar

Drugs with a possible risk for QT prolongation and TdP that should be used cautiously inssrt flecainide include the beta-agonists. Minor The use of bretylium a class III antiarrhythmic agent in conjunction with other drugs associated with QT insrt should be used with caution due to the potential risk for ventricular tachycardia, including torsade de pointes. Oral albuterol sulfate has been shown to delay preterm labor in some reports.

The recommended dose of DuoNeb is one 3 mL vial administered 4 times per day via nebulization with up to 2 additional 3 mL doses allowed per day, if needed. This risk may be lower with short-acting beta-agonists as compared to long-acting beta-agonists. It should be used with caution in these patient populations.

Ipratropium Bromide mg and Albuterol Sulfate 3mg | Nephron Pharmaceuticals

Minor Consider increased frequency of ECG monitoring if coadministration of glasdegib and short-acting beta-agonists is necessary. Drugs with a possible risk for QT prolongation that should be used cautiously with vemurafenib include the beta-agonists. DuoNeb demonstrated significantly better changes in FEV 1as measured from baseline to peak response, when compared with either albuterol sulfate or ipratropium bromide.

A mean of 8. Following intravenous administration, approximately one-half is excreted unchanged in the urine.

Thyroid hormones may increase the risk of coronary insufficiency when sympathomimetic agents are administered to patients with coronary artery disease. Minor Consider periodic monitoring of EGCs for QT prolongation and monitor electrolytes if coadministration of histrelin and short-acting beta-agonists is necessary; correct any electrolyte abnormalities.


The manufacturer of osimertinib recommends avoiding coadministration with other drugs that prolong the QT, if possible; if unavoidable, periodically monitor ECGs for QT prolongation and monitor electrolytes. Beta agonists infrequently produce cardiovascular adverse effects, mostly with high doses or in the setting of beta-agonist-induced hypokalemia.

IPRATROPIUM BROMIDE and ALBUTEROL SULFATE Inhalation Solution (DuoNeb) 05 mg30 mg | Mylan

Prescribers need to weigh the potential benefits and risks of degarelix use in patients with prolonged QT syndrome or in patients taking other drugs that may prolong the QT interval. The effects of beta-agonists inesrt be reduced with concurrent use of sotalol, which is a non-selective beta-blocker.

Albuterol hypersensitivity, levalbuterol hypersensitivity, paradoxical bronchospasm. Minor Since degarelix can cause QT prolongation, degarelix should be used cautiously with other drugs udoneb are associated with QT prolongation. This risk may be more clinically significant with long-acting beta-agonists versus short-acting beta-agonists such as albuterol or levalbuterol.

Minor The administration of artemether; lumefantrine is associated with prolongation of the QT interval.

PDR Search

Related Drug Information Drug Summary. Chlorpromazine is specifically associated with an established risk of QT prolongation and TdP; case reports have included patients receiving therapeutic doses of chlorpromazine. Minor Due to a possible risk for QT prolongation and torsade de pointes TdPazithromycin and short-acting beta-agonists should be used together cautiously. Drugs with a possible risk for QT prolongation include beta-agonists. Albuterol inhalation is classified as a category C drug.

The manufacturer warns duomeb the QT effect of alfuzosin should be considered prior to administering the drug to patients taking other medications known to prolong the QT interval. Intracellularly, the actions of albuterol are mediated by cAMP, the production of which is augmented by beta-stimulation.

Albuterol has been shown in most controlled clinical trials to have more effect on the respiratory tract, in the form of bronchial smooth muscle relaxation, than isoproterenol at comparable doses while producing fewer cardiovascular effects. The maximal change in the QTc interval occurs approximately 5 to 10 hours following oral administration of gemifloxacin.


Rare cases of torsade de pointes TdP have been reported during postmarketing surveillance in patients receiving levofloxacin. Drugs with a possible risk for QT prolongation that should be used cautiously with tolterodine include the beta-agonists.

Mylan Worldwide

Minor There may be an increased risk for QT prolongation and torsade de pointes TdP during concurrent use of mirtazapine and short-acting beta-agonists. Coadministration with other drugs that have a possible risk for QT prolongation and torsade de pointes TdPsuch as beta-agonists, should be done with caution and close monitoring.

Additionally, beta -agonists may cause a decrease in serum potassium in some patients, possibly through intracellular shunting. It has a molecular weight of Atropine, a drug related to ipratropium, is usually considered compatible with breast-feeding by the American Academy of Pediatrics.

Using the ‘blow by’ technique i. Avoid concurrent use of quinine with other drugs that may cause QT prolongation and TdP including beta-agonists. Monitor the patients lung and cardiovascular status closely.

Maternal and fetal tachycardia and maternal hypotension have occurred with systemic use of the beta-agonists. Clinical studies of albuterol; ipratropium inhalers and nebulizer solutions have included a fair percentage of older adults 65 years and over, and patients 75 years of age and older.

The Combivent albuterol; ipratropium aerosol contains flammable ingredients under pressure. The effect of vardenafil on the QT interval should be considered when prescribing duineb drug.

Use cautiously with promethazine, which has been reported to cause QT prolongation.